CMV

COMMUNIQUÉS West-GlobeNewswire

Norton Children’s announces new pediatric care campus, second dedicated pediatric hospital
11/06/2025
New campus will expand specialty care and research for children from across the region LOUISVILLE, Ky., June 11, 2025 (GLOBE NEWSWIRE) -- Norton Children’s , a comprehensive pediatric health care system based in [...]
Result of General Meeting
11/06/2025
June 11, 2025 Biodexa Pharmaceuticals PLC Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative [...]
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
11/06/2025
Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – [...]
DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2025
11/06/2025
Châtillon, France, le 11 juin 2025 DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2025 Toutes les résolutions proposées à l’Assemblée Générale ont été adoptées DBV Technologies (Euronext : DBV – [...]
Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
11/06/2025
Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private [...]
Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
11/06/2025
Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private [...]
AIM ImmunoTech Announces 1-for-100 Reverse Stock Split
11/06/2025
OCALA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (OTC Pink: AIMID) (NYSE American: AIM) (“AIM” or the “Company”) today announced a reverse stock split (“Reverse Stock Split”) of its shares at a ratio [...]
Fortrea Names Anshul Thakral Chief Executive Officer
11/06/2025
Thakral succeeds Interim CEO, Peter M. Neupert, who will remain chairman of the board DURHAM, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research [...]
Allarity Therapeutics Announces Changes to Board of Directors
11/06/2025
TARPON SPRINGS, Fla., June 11, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual [...]
SRx Health Solutions Announces Management and Board Changes
11/06/2025
TAMPA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced the following management team and Board of [...]
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
11/06/2025
CAMBRIDGE, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational [...]
Abivax Announces Results of its June 6, 2025 Annual General Meeting
11/06/2025
Abivax Announces Results of its June 6, 2025 Annual General Meeting PARIS, France, June 11, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical [...]
BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG
11/06/2025
WOBURN, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), confirms a disclosure by the [...]
SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide
11/06/2025
IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its [...]
KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders
11/06/2025
RIYADH, Saudi Arabia, June 11, 2025 (GLOBE NEWSWIRE) -- In a landmark medical achievement, King Faisal Specialist Hospital & Research Centre (KFSHRC) has become the first institution in the Middle East to [...]
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
11/06/2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Shareholders approve all proposed resolutions EINDHOVEN, The Netherlands, June 11, [...]
PAT (ALPAT) : Attribution gratuite de bons de souscription d'actions remboursables au bénéfice de tous les actionnaires de la Société
11/06/2025
Vandœuvre-lès-Nancy, le 11 juin 2025 – 19 : 00 (CET) Communiqué de presse Pour diffusion immédiate Attribution gratuite de bons de souscription d'actions remboursables au bénéfice de tous les actionnaires de la Société [...]
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025
11/06/2025
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025 NANTES, France, June 11, 6:30 PM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the cancellation of the convening of the [...]
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025
11/06/2025
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025 NANTES, France, 11 juin 2025, 18 heures 30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce l'annulation de la [...]

Pages